EMERYVILLE, CA: David Weiskopf has joined biotech company Chiron as VP of corporate communications, overseeing all external and internal communications, except for IR.
Weiskopf joins as the company is under investigation by the Securities and Exchange Commission for possible violations of federal securities laws.
The company has also seen its reputation and stock price suffer after it failed to deliver large stocks of flu vaccine, greatly diminishing the US' supply this winter.
"This is a great company that is doing exciting work," said Weiskopf, who declined to comment on the investigation or vaccine snafu. "I felt I could help the company be more effective from a communications standpoint."
Weiskopf was previously an SVP and associate director in Ketchum's San Francisco office, where he worked with clients including Genentech.